Home » Health » Inmegen analyzes samples to identify COVID-19 variants – N+

Inmegen analyzes samples to identify COVID-19 variants – N+

The study of the DNA sequence of SARS Cov-2 that causes the COVID-19 it has been a key piece in facing the pandemic; before this the National Institute of Genomic Medicine (Inmegen) has analyzed more than 700 thousand samples to identify the new variants, as well as the behavior of the virus.

We recommend you: 70% of the people who died in the fifth wave of COVID-19 were not vaccinated: López-Gatell

The study of genes makes it possible to promote timely diagnosis, as well as personalized treatments that prevent diseases from getting worse.

“The genetic information of our population will help us organize faster and more accurate diagnoses to select better treatments and predictions that reduce the risk of serious disease in people”pointed out Luis Herrera Montalvo, general director of the National Institute of Genomic Medicine.

Genomics also has applications ranging from early surveillance, which makes it possible to detect genetic mutations that cause breast and ovarian cancer, to the opportunity to identify the remains of missing persons.

The National Institute of Genomic Medicine celebrated its 18th anniversary.

With information from Mónica Garduño.

LLH

<!– –>-

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.